pRS415-TEF1pr-STE3-GFP
(Plasmid
#221113)
-
PurposeGFP-tagged STE3 (C-terminally tagged, optimized for yeast expression)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 221113 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRS415
-
Vector typeYeast Expression
-
Selectable markersLEU2
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameSTE3-GFP
-
SpeciesS. cerevisiae (budding yeast)
- Promoter TEF1
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Unknown (unknown if destroyed)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The pRS415-TEF1pr plasmid (Mumberg et al., 1995) was used to insert the Ste3 coding sequence fused at the C-terminus to GFP. The GFP was inserted into the plasmid first between the XhoI and SalI restriction enzyme sites and then Ste3 coding sequence (lacking the stop codon) was inserted into the SpeI and SmaI restriction enzyme sites.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRS415-TEF1pr-STE3-GFP was a gift from Allyson O’Donnell (Addgene plasmid # 221113 ; http://n2t.net/addgene:221113 ; RRID:Addgene_221113) -
For your References section:
Optimization of the fluorogen-activating protein tag for quantitative protein trafficking and colocalization studies in S. cerevisiae. Oppenheimer KG, Hager NA, McAtee CK, Filiztekin E, Shang C, Warnick JA, Bruchez MP, Brodsky JL, Prosser DC, Kwiatkowski AV, O'Donnell AF. Mol Biol Cell. 2024 Jul 1;35(7):mr5. doi: 10.1091/mbc.E24-04-0174. Epub 2024 May 29. 10.1091/mbc.E24-04-0174 PubMed 38809589